Diabetes

n-3 PUFA may reduce markers of kidney disease in T2DM

(HealthDay)—In patients with type 2 diabetes and evidence of kidney injury, supplementation with n-3 long-chain polyunsaturated fatty acids (PUFA) does not reduce urine albumin excretion but is associated with a reduction ...

Medical research

Research opens way to significant improvements for medication

International research co-authored by the University of Otago, Christchurch has unraveled a century old scientific mystery, opening the way to significant improvements in the way drugs are delivered to the body.

page 2 from 2